Keyword Search Results for "STEMI"

Hillis, L. D., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial Journal of the American College of Cardiology. 1985;6(5):957-62. Abstract

Williams, D. O., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial Circulation. 1986;73(2):338-46. Abstract

Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., Ludbrook, P., et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation. 1987;76(1):142-54. Abstract

Gore, J. M., Roberts, R., Ball, S. P., Montero, A., Goldberg, R. J., Dalen, J. E. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction American Journal of Cardiology. 1987;59(15):1234-8. Abstract

Holmes, D. R., Jr., Bove, A. A., Nishimura, R. A., Gehring, D. G., Chesebro, J. H., Owen, R. M., Smith, H. C. Comparison of monoplane and biplane assessment of regional left ventricular wall motion after thrombolytic therapy for acute myocardial infarction American Journal of Cardiology. 1987;59(8):793-7. Abstract

Owen, J., Friedman, K. D., Grossman, B. A., Wilkins, C., Berke, A. D., Powers, E. R. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator Journal of clinical investigation. 1987;79(6):1642-7. Abstract

Passamani, E., Hodges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., et al., The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1987;10(5 Suppl 2):51B-64B. Abstract

Sheehan, F. H., Braunwald, E., Canner, P., Dodge, H. T., Gore, J., Van Natta, P., Passamani, E. R., Williams, D. O., Zaret, B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial Circulation. 1987;75(4):817-29. Abstract

Williams, D. O., Ruocco, N. A., Forman, S. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1987;10(5 Suppl B):45B-50B. Abstract

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group JAMA. 1988;260:2849-58. Abstract

Dalen, J. E., Gore, J. M., Braunwald, E., Borer, J., Goldberg, R. J., Passamani, E. R., Forman, S., Knatterud, G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial American Journal of Cardiology. 1988;62(4):179-85. Abstract

Rao, A. K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T. L., Bell, W. R., Knatterud, G., Robertson, T. L., Terrin, M. L. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Journal of the American College of Cardiology. 1988;11(1):11-Jan. Abstract

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27. Abstract

Chaitman, B. R., Thompson, B., Wittry, M. D., Stump, D., Hamilton, W. P., Hillis, L. D., Dwyer, J. G., Solomon, R. E., Knatterud, G. L. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators Journal of the American College of Cardiology. 1989;14(5):1159-65. Abstract

Gibbons, R. J., Verani, M. S., Behrenbeck, T., Pellikka, P. A., O'Connor, M. K., Mahmarian, J. J., Chesebro, J. H., Wackers, F. J. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction Circulation. 1989;80(5):1277-86. Abstract

Gore, J. M., Corrao, J. M., Goldberg, R. J., Ball, S. P., Weiner, B. H., Aghababian, R. V., Dalen, J. E. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction Archives of internal medicine. 1989;149(2):353-5. Abstract

Wackers, F. J., Gibbons, R. J., Verani, M. S., Kayden, D. S., Pellikka, P. A., Behrenbeck, T., Mahmarian, J. J., Zaret, B. L. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy Journal of the American College of Cardiology. 1989;14(4):861-73. Abstract

Wackers, F. J., Terrin, M. L., Kayden, D. S., Knatterud, G., Forman, S., Braunwald, E., Zaret, B. L. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial Journal of the American College of Cardiology. 1989;13(5):998-1005. Abstract

Chaitman, B. R., Thompson, B. W., Kern, M. J., Vandormael, M. G., Cohen, M. B., Ruocco, N. A., Solomon, R. E., Braunwald, E. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators American heart journal. 1990;119(2 Pt 1):213-23. Abstract

Feit, F., Mueller, H. S., Braunwald, E., Ross, R., Hodges, M., Herman, M. V., Knatterud, G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group Journal of the American College of Cardiology. 1990;16(7):1529-34. Abstract

Gertz, S. D., Kalan, J. M., Kragel, A. H., Roberts, W. C., Braunwald, E. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator American Journal of Cardiology. 1990;65(15):953-61. Abstract

Gertz, S. D., Kragel, A. H., Kalan, J. M., Braunwald, E., Roberts, W. C. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators American Journal of Cardiology. 1990;66(12):904-9. Abstract

Hillis, L. D., Forman, S., Braunwald, E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators Journal of the American College of Cardiology. 1990;16(2):313-5. Abstract

Kayden, D. S., Wackers, F. J., Zaret, B. L. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. 1990;15(7):1500-7. Abstract

Lawler, C. M., Bovill, E. G., Stump, D. C., Collen, D. J., Mann, K. G., Tracy, R. P. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood. 1990;76(7):1341-8. Abstract

Rogers, W. J., Baim, D. S., Gore, J. M., Brown, B. G., Roberts, R., Williams, D. O., Chesebro, J. H., Babb, J. D., Sheehan, F. H., Wackers, F. J., et al., Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation. 1990;81(5):1457-76. Abstract

Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al., Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Annals of internal medicine. 1991;115(4):256-65. Abstract

Gore, J. M., Sloan, M., Price, T. R., Randall, A. M., Bovill, E., Collen, D., Forman, S., Knatterud, G. L., Sopko, G., Terrin, M. L. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial Circulation. 1991;83(2):448-59. Abstract

Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83:739-46. Abstract

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. Abstract

Zaret, Barry L., Wackers, Frans J., Terrin, Michael, Ross, Richard, Knatterud, Genell, Braunwald, Eugene Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trail Journal of the American College of Cardiology. 1991;17(2, Supplement 1):A214.

Baim, D. S., Diver, D. J., Feit, F., Greenberg, M. A., Holmes, D. R., Weiner, B. H., Williams, D. O., Schweiger, M. J., Brown, B. G., Frederick, M. M., et al., Coronary angioplasty performed within the Thrombolysis in Myocardial Infarction II study Circulation. 1992;85(1):93-105. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Frederick, M. M., Jacobs, A. K., Faxon, D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II Journal of the American College of Cardiology. 1992;20(3):533-40. Abstract

Kleiman, N. S., Terrin, M., Mueller, H., Chaitman, B., Roberts, R., Knatterud, G. L., Solomon, R., McMahon, R. P., Braunwald, E. Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study Journal of the American College of Cardiology. 1992;19(6):1129-35. Abstract

Ruocco, N. A., Jr., Bergelson, B. A., Jacobs, A. K., Frederick, M. M., Faxon, D. P., Ryan, T. J. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II) Journal of the American College of Cardiology. 1992;20(7):1445-51. Abstract

Tofler, G. H., Muller, J. E., Stone, P. H., Forman, S., Solomon, R. E., Knatterud, G. L., Braunwald, E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group Journal of the American College of Cardiology. 1992;20(5):1049-55. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Jacobs, A. K., Zaret, B. L., Wackers, F. J., Frederick, M. M., Faxon, D. P. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group American journal of cardiology. 1993;71(13):1148-52. Abstract

Berger, P. B., Ruocco, N. A., Ryan, T. J., Frederick, M. M., Podrid, P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial Journal of the American College of Cardiology. 1993;22(7):1773-9. Abstract

Chaitman, B. R., McMahon, R. P., Terrin, M., Younis, L. T., Shaw, L. J., Weiner, D. A., Frederick, M. M., Knatterud, G. L., Sopko, G., Braunwald, E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial American journal of cardiology. 1993;71(2):131-8. Abstract

Lehmann, K. G., Francis, C. K., Sheehan, F. H., Dodge, H. T. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1993;22(3):714-9. Abstract

Simoons, M. L., Maggioni, A. P., Knatterud, G., Leimberger, J. D., de Jaegere, P., van Domburg, R., Boersma, E., Franzosi, M. G., Califf, R., Schroder, R., et al., Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet. 1993;342(8886-8887):1523-8. Abstract

Terrin, M. L., Williams, D. O., Kleiman, N. S., Willerson, J., Mueller, H. S., Desvigne-Nickens, P., Forman, S. A., Knatterud, G. L., Braunwald, E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial Journal of the American College of Cardiology. 1993;22(7):1763-72. Abstract

Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., Hamilton, W. P., Chaitman, B. R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators Circulation. 1994;90(1):78-86. Abstract

Becker, R. C., Terrin, M., Ross, R., Knatterud, G. L., Desvigne-Nickens, P., Gore, J. M., Braunwald, E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators Annals of internal medicine. 1994;120(8):638-45. Abstract

Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol. 1994;23:993-1003. Abstract

Cannon, C. P., Antman, E. M., Walls, R., Braunwald, E. Time as an Adjunctive Agent to Thrombolytic Therapy J Thromb Thrombolysis. 1994;1(1):27-34. Abstract

Cox, D. A., Rogers, W. J., Aguirre, F. V., Forman, S., Solomon, R., Zaret, B. L. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators American journal of cardiology. 1994;73(11):729-36. Abstract

Schweiger, M. J., McMahon, R. P., Terrin, M. L., Ruocco, N. A., Porway, M. N., Wiseman, A. H., Knatterud, G. L., Braunwald, E. Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators American journal of cardiology. 1994;74(2):105-10. Abstract

Gersh, B. J., Chesebro, J. H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R. E., Ross, A. M., Ross, R., Terrin, M. L., Knatterud, G. L. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II) Journal of the American College of Cardiology. 1995;25(2):395-402. Abstract

Gibson, C. M., Cannon, C. P., Piana, R. N., Breall, J. A., Sharaf, B., Flatley, M., Alexander, B., Diver, D. J., McCabe, C. H., Flaker, G. C., et al., Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial Journal of the American College of Cardiology. 1995;25(3):582-9. Abstract

Hall, C., Cannon, C. P., Forman, S., Braunwald, E. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators Journal of the American College of Cardiology. 1995;26(6):1452-6. Abstract

Kloner, R. A., Shook, T., Przyklenk, K., Davis, V. G., Junio, L., Matthews, R. V., Burstein, S., Gibson, M., Poole, W. K., Cannon, C. P., et al., Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 1995;91(1):37-45. Abstract

Lee, LV. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial Am J Cardiol. 1995;75:7-13. Abstract

McKendall, G. R., Forman, S., Sopko, G., Braunwald, E., Williams, D. O. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators American Journal of Cardiology. 1995;76(16):1108-11. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Davis, V., Braunwald, E., Shah, P. K. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) American journal of cardiology. 1995;75(4):232-6. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Shah, P. K. Thrombolytic Therapy for Acute Myocardial Infarction in Patients with Prior Coronary Bypass Surgery: Results from the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial Journal of thrombosis and thrombolysis. 1995;2(1):45-50. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Forman, S. A., Williams, D. O., Knatterud, G. L., Braunwald, E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group Journal of the American College of Cardiology. 1995;26(1):73-9. Abstract

Birnbaum, Y., Kloner, R. A., Sclarovsky, S., Cannon, C. P., McCabe, C. H., Davis, V. G., Zaret, B. L., Wackers, F. J., Braunwald, E. Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial) American journal of cardiology. 1996;78(4):396-403. Abstract

Gibson, C. M., Cannon, C. P., Daley, W. L., Dodge, J. T., Jr., Alexander, B., Jr., Marble, S. J., McCabe, C. H., Raymond, L., Fortin, T., Poole, W. K., Braunwald, E. TIMI frame count: a quantitative method of assessing coronary artery flow Circulation. 1996;93(5):879-88. Abstract

Scharfstein, J. S., Abendschein, D. R., Eisenberg, P. R., George, D., Cannon, C. P., Becker, R. C., Sobel, B., Cupples, L. A., Braunwald, E., Loscalzo, J. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction American journal of cardiology. 1996;78(5):503-10. Abstract

Cannon, C. P., Sharis, P. J., Schweiger, M. J., McCabe, C. H., Diver, D. J., Shah, P. K., Sequeira, R. F., Greene, R. M., Perritt, R. L., Poole, W. K., Braunwald, E. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction American journal of cardiology. 1997;80(6):696-9. Abstract

Gibson, C. M., Cannon, C. P., Greene, R. M., Sequeira, R. F., Margorien, R. D., Leya, F., Diver, D. J., Baim, D. S., Braunwald, E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial American journal of cardiology. 1997;80(1):21-6. Abstract

Gibson, C. M., Marble, S. J., Rizzo, M. J., Moynihan, J., McLean, C., Ryan, K., Sparano, A., Piana, R. N., McCabe, C., Cannon, C. P. Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trial American heart journal. 1997;134(3):351-4. Abstract

Sloan, M. A., Price, T. R., Terrin, M. L., Forman, S., Gore, J. M., Chaitman, B. R., Hodges, M., Mueller, H., Rogers, W. J., Knatterud, G. L., Braunwald, E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience Stroke. 1997;28(6):1107-14. Abstract

Tanasijevic, M. J., Cannon, C. P., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Antman, E. M., Braunwald, E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A American heart journal. 1997;134(4):622-30. Abstract

Callas, P. W., Tracy, R. P., Bovill, E. G., Cannon, C., Thompson, B., Mann, K. G. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial Journal of thrombosis and thrombolysis. 1998;5(1):53-60. Abstract

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 1998;98:2805-14. Abstract

Goel, M., Dodge Jr, J. T., Rizzo, M., McLean, C., Ryan, K. A., Daley, W. L., Cannon, C. P., Gibson, C. M. The Open Artery Hypothesis: Past, Present, and Future J Thromb Thrombolysis. 1998;5(2):101-112. Abstract

Kloner, R. A., Przyklenk, K., Shook, T., Cannon, C. P. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial Journal of thrombosis and thrombolysis. 1998;6(2):89-92. Abstract

Modi, N. B., Eppler, S., Breed, J., Cannon, C. P., Braunwald, E., Love, T. W. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction Thrombosis and haemostasis. 1998;79(1):134-9. Abstract

Sagarin, M. J., Cannon, C. P., Cermignani, M. S., Scirica, B. M., Walls, R. M. Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect J Emerg Med. 1998;16(4):557-65. Abstract

Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation. 1999;99:2720-32. Abstract

Becker, R. C., Hochman, J. S., Cannon, C. P., Spencer, F. A., Ball, S. P., Rizzo, M. J., Antman, E. M. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study Journal of the American College of Cardiology. 1999;33(2):479-87. Abstract

Cannon, C. P., Johnson, E. B., Cermignani, M., Scirica, B. M., Sagarin, M. J., Walls, R. M. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction Clin Cardiol. 1999;22(1):17-20. Abstract

Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Van de Werf, F., Braunwald, E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99(15):1945-50. Abstract

Gibson, C. M., Murphy, S., Menown, I. B., Sequeira, R. F., Greene, R., Van de Werf, F., Schweiger, M. J., Ghali, M., Frey, M. J., Ryan, K. A., Marble, S. J., Giugliano, R. P., Antman, E. M., Cannon, C. P., Braunwald, E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1999;34(5):1403-12. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Braunwald, E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B J Am Coll Cardiol. 1999;34(3):739-47. Abstract

Antman, E. M., Gibson, C. M., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Coussement, P., Menown, I., Nienaber, C. A., Rehders, T. C., Frey, M. J., Van der Wieken, R., Andresen, D., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators Eur Heart J. 2000;21(23):1944-53. Abstract

Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation. 2000;102(19):2329-34. Abstract

Cannon, C. P. Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI J Thromb Thrombolysis. 2000;9(3):235-41. Abstract

Cannon, C. P., Sayah, A. J., Walls, R. M. ER TIMI-19: testing the reality of prehospital thrombolysis J Emerg Med. 2000;19(3 Suppl):21S-25S.

Cohen, M., Antman, E. M., Gurfinkel, E., Turpie, A. G., Furst, J., Bigonzi, F., Radley, D. Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Am J Cardiol. 2000;86(5):553-6, A9. Abstract

Gibson, C. M., Anshelevich, M., Murphy, S., Luu, L., Hynes, C., Kliris, J., Kermgard, S., Otten, M. H., Antman, E. M., Cannon, C. P., Braunwald, E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;86(12):1378-9, A5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Ryan, K. A., Mesley, R., Marble, S. J., McCabe, C. H., Van De Werf, F., Braunwald, E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation. 2000;101(2):125-30. Abstract

Llevadot, J., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Antman, E. M., Murphy, S., Gibson, C. M. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials) Am J Cardiol. 2000;85(12):1409-13. Abstract

Modi, N. B., Fox, N. L., Clow, F. W., Tanswell, P., Cannon, C. P., Van de Werf, F., Braunwald, E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction J Clin Pharmacol. 2000;40(5):508-15. Abstract

Morrow, D. A., Antman, E. M., Charlesworth, A., Cairns, R., Murphy, S. A., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Braunwald, E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation Circulation. 2000;102(17):2031-7. Abstract

The InTIMI-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005-13. Abstract

de Lemos, J. A., Antman, E. M., Gibson, C. M., McCabe, C. H., Giugliano, R. P., Murphy, S. A., Coulter, S. A., Anderson, K., Scherer, J., Frey, M. J., Van Der Wieken, R., Van De Werf, F., Braunwald, E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial Circulation. 2000;101(3):239-43. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., McCabe, C. H., Murphy, S. A., Van de Werf, F., Gibson, C. M., Braunwald, E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators Am J Cardiol. 2000;85(3):299-304. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Charlesworth, A., Schroder, R., Braunwald, E. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram Am Heart J. 2000;140(3):373-8. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Cutler, S. S., Charlesworth, A., Schroder, R., Braunwald, E. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II Am J Cardiol. 2000;86(11):1235-7, A5. Abstract

de Lemos, J. A., Antman, E. M., Morrow, D. A., Llevadot, J., Giugliano, R. P., Coulter, S. A., Schuhwerk, K. C., Arslanian, S., McCabe, C. H., Gibson, C. M., Rifai, N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy Clin Chim Acta. 2000;298(2-Jan):85-97. Abstract

Blazing, M. A., De Lemos, J. A., Dyke, C. K., Califf, R. M., Bilheimer, D., Braunwald, E. The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy Am Heart J. 2001;142(2):211-7.

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Marble, S. J., de Lemos, J. A., Antman, E. M., Braunwald, E. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction Catheter Cardiovasc Interv. 2001;53(1):11-Jun. Abstract

Gibson, C. M., Marble, S. J. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) Clin Cardiol. 2001;24(9):577-84. Abstract

Gibson, C. M., Murphy, S. A., Marble, S. J., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group Am J Cardiol. 2001;87(4):450-3, A6. Abstract

Giugliano, R. P., Llevadot, J., Wilcox, R. G., Gurfinkel, E. P., McCabe, C. H., Charlesworth, A., Thompson, S. L., Antman, E. M., Braunwald, E. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J. 2001;22(18):1702-15. Abstract

Llevadot, J., Giugliano, R. P., Antman, E. M., Wilcox, R. G., Gurfinkel, E. P., Henry, T., McCabe, C. H., Charlesworth, A., Thompson, S., Nicolau, J. C., Tebbe, U., Sadowski, Z., Braunwald, E. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction Eur Heart J. 2001;22(22):2104-15. Abstract

Morrow, D. A., Antman, E. M., Giugliano, R. P., Cairns, R., Charlesworth, A., Murphy, S. A., de Lemos, J. A., McCabe, C. H., Braunwald, E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy Lancet. 2001;358(9293):1571-5. Abstract

Morrow, D. A., Antman, E. M., Parsons, L., de Lemos, J. A., Cannon, C. P., Giugliano, R. P., McCabe, C. H., Barron, H. V., Braunwald, E. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA. 2001;286(11):1356-9. Abstract

Roe, Matthew T., Giugliano, Robert P., Harrington, Robert A., Gibson, C. Michael, Strony, John, Kitt, Michael M., Califf, Robert M., Braunwald, Eugene Combination reperfusion therapy with eptifibatide and tenecteplase for acute myocardial infarction. Design and methodology of the INTEGRITI (Integrilin and Tenecteplase for Acute Myocardial Infarction) trial HeartDrug. 2001;1(1):13-May.

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., Mueller, H. S. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy Am Heart J. 2001;142(1):29-36. Abstract

de Lemos, J. A., Gibson, C. M., Antman, E. M., Murphy, S. A., Morrow, D. A., Schuhwerk, K. C., Schweiger, M., Coussement, P., Van de Werf, F., Braunwald, E. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial Am Heart J. 2001;141(4):592-8. Abstract

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Rifai, N., Tanasijevic, M., Giugliano, R. P., Schuhwerk, K. C., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy Am J Cardiol. 2001;88(4):353-8. Abstract

Angeja, B. G., Kermgard, S., Chen, M. S., McKay, M., Murphy, S. A., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis. 2002;13(3):133-9. Abstract

Angeja, B. G., de Lemos, J., Murphy, S. A., Marble, S. J., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy Am Heart J. 2002;144(4):649-56. Abstract

Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation. 2002;105:1642-9.

Antman, E. M., Cooper, H. A., Gibson, C. M., de Lemos, J. A., McCabe, C. H., Giugliano, R. P., Coussement, P., Murphy, S., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II Eur Heart J. 2002;23(12):928-33. Abstract

Bahit, M. C., Murphy, S. A., Gibson, C. M., Cannon, C. P. Critical pathway for acute ST-segment elevation myocardial infarction: estimating its potential impact in the TIMI 9 Registry Critical pathways in cardiology. 2002;1(2):107-12. Abstract

Cannon CP, Bahit MC, Haugland JM, Henry TD, Schweiger MJ, McKendall GR, Shah PK, Murphy S, Gibson CM, McCabe CH, Antman EM, Braunwald E. Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry Crit Pathw Cardiol. 2002;1:44-52. Abstract

Cooper, H. A., de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Gibson, C. M., Antman, E. M., Braunwald, E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration Am Heart J. 2002;144(5):790-5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Marble, S. J., Barron, H. V., Braunwald, E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation. 2002;105(16):1909-13. Abstract

Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, deLemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald E. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002;40:71-7.

Murphy, S. A., Chen, C., Cannon, C. P., Antman, E. M., Gibson, C. M. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction Am J Cardiol. 2002;90(7):766-70.

Weber, J. E., Hollander, J. E., Murphy, S. A., Braunwald, E., Gibson, C. M. Quantitative comparison of coronary artery flow and myocardial perfusion in patients with acute myocardial infarction in the presence and absence of recent cocaine use J Thromb Thrombolysis. 2002;14(3):239-45. Abstract

Wong, G. C., Morrow, D. A., Murphy, S., Kraimer, N., Pai, R., James, D., Robertson, D. H., Demopoulos, L. A., DiBattiste, P., Cannon, C. P., Gibson, C. M. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction Circulation. 2002;106(2):202-7.

Bahit, M. C., Cannon, C. P., Antman, E. M., Murphy, S. A., Gibson, C. M., McCabe, C. H., Braunwald, E. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry American heart journal. 2003;145(1):109-17. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., James, D., Morrow, D. A., Cannon, C. P., Giugliano, R. P., Antman, E. M., Braunwald, E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials J Am Coll Cardiol. 2003;42(1):16-Jul. Abstract

Gibson, C. M., Pinto, D. S., Murphy, S. A., Morrow, D. A., Hobbach, H. P., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol. 2003;42(9):1535-43. Abstract

Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, Greenberg S, Miller J, Kitt MM, Strony J, McCabe CH, Braunwald E, Califf RM. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol. 2003;41:1251-60.

Karha, J., Murphy, S. A., Kirtane, A. J., de Lemos, J. A., Aroesty, J. M., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction Am J Cardiol. 2003;92(8):913-8. Abstract

Wong, G. C., Frisch, D., Murphy, S. A., Sabatine, M. S., Pai, R., James, D., Kraimer, N., Katsiyiannis, P. T., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Gourlay, S. G., Barron, H. V., Cannon, C. P., Gibson, C. M. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction Am J Cardiol. 2003;91(10):1163-7.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.

Gibson, C. M., Bigelow, B., James, D., Tepper, M. R., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction Am J Cardiol. 2004;94(1):108-11. Abstract

Gibson, C. M., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Eur Heart J. 2004;25(22):1998-2005. Abstract

Gibson, C. M., Jennings, L. K., Murphy, S. A., Lorenz, D. P., Giugliano, R. P., Harrington, R. A., Cholera, S., Krishnan, R., Califf, R. M., Braunwald, E. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy Circulation. 2004;110(6):679-84.

Gibson, C. M., Karha, J., Giugliano, R. P., Roe, M. T., Murphy, S. A., Harrington, R. A., Green, C. L., Schweiger, M. J., Miklin, J. S., Baran, K. W., Palmeri, S., Braunwald, E., Krucoff, M. W. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction Am Heart J. 2004;147(5):847-52.

Gibson, C. M., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(5):980-7. Abstract

Gibson, C. M., Murphy, S. A., Morrow, D. A., Aroesty, J. M., Gibbons, R. J., Gourlay, S. G., Barron, H. V., Giugliano, R. P., Antman, E. M., Braunwald, E. Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction American Heart Journal. 2004;148(2):336-340. Abstract

Giugliano, R. P., Sabatine, M. S., Gibson, C. M., Roe, M. T., Harrington, R. A., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion Am J Cardiol. 2004;93(11):1362-7, A5-6. Abstract

Karmpaliotis, D., Turakhia, M. P., Kirtane, A. J., Murphy, S. A., Kosmidou, I., Morrow, D. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction Am J Cardiol. 2004;94(9):1113-7. Abstract

Kirtane, A. J., Bui, A., Murphy, S. A., Karmpaliotis, D., Kosmidou, I., Boundy, K., Rahman, A., Pinto, D. S., Aroesty, J. M., Giugliano, R. P., Cannon, C. P., Antman, E. M., Gibson, C. M. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction J Thromb Thrombolysis. 2004;17(3):177-84. Abstract

Mega, J. L., Morrow, D. A., De Lemos, J. A., Sabatine, M. S., Murphy, S. A., Rifai, N., Gibson, C. M., Antman, E. M., Braunwald, E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol. 2004;44(2):335-9. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Assmann, S. F., Giugliano, R. P., Cannon, C. P., Michael Gibson, C., McCabe, C. H., Barron, H. V., Van De Werf, F., Braunwald, E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies Eur Heart J. 2004;25(13):1139-45. Abstract

Roe, M. T., Green, C. L., Giugliano, R. P., Gibson, C. M., Baran, K., Greenberg, M., Palmeri, S. T., Crater, S., Trollinger, K., Hannan, K., Harrington, R. A., Krucoff, M. W. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;43(4):549-56.

Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., Lee, R. T. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation. 2004;109(18):2186-90. Abstract

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):783-9. Abstract

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Brady, W. E., White, H. D., Fox, K. A., Palmisano, J., Ramsey, K. E., Bilheimer, D. W., Lewis, E. F., Pfeffer, M., Califf, R. M., Braunwald, E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial Eur Heart J. 2004;25(19):1688-94.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A., White, H. D., Rouleau, J. L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., Ramsey, K. E., Palmisano, J., Bilheimer, D. W., Pfeffer, M. A., Califf, R. M., Braunwald, E. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA. 2004;292(11):1307-16.

ADVANCE MI Investigators Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial Am Heart J. 2005;150(1):116-22.

Antman, E. M., Morrow, D. A., McCabe, C. H., Jiang, F., White, H. D., Fox, K. A., Sharma, D., Chew, P., Braunwald, E. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) Am Heart J. 2005;149(2):217-26.

Gibson, C. M., Kirtane, A. J., Boundy, K., Ly, H., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients J Am Coll Cardiol. 2005;45(3):357-62. Abstract

Kashani, A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(2):228-33. Abstract

Kirtane, A. J., Kosmidou, I., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Cardiol. 2005;95(3):337-42. Abstract

Kirtane, A. J., Weisbord, A., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Ohman, E. M., Roe, M. T., Braunwald, E., Gibson, C. M. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction Am J Cardiol. 2005;95(2):224-7. Abstract

Ly, H. Q., Kirtane, A. J., Buros, J., Giugliano, R. P., Popma, J. J., Antman, E. M., Harrington, R. A., Ohman, E. M., Gibson, C. M. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(3):383-6. Abstract

Ohman, E. M., Van de Werf, F., Antman, E. M., Califf, R. M., de Lemos, J. A., Gibson, C. M., Oliverio, R. L., Harrelson, L., McCabe, C., DiBattiste, P., Braunwald, E. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial Am Heart J. 2005;150(1):79-88.

Pinto, D. S., Skolnick, A. H., Kirtane, A. J., Murphy, S. A., Barron, H. V., Giugliano, R. P., Cannon, C. P., Braunwald, E., Gibson, C. M. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2005;46(1):178-80.

Ray, K. K., Morrow, D. A., Gibson, C. M., Murphy, S., Antman, E. M., Braunwald, E. Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy Eur Heart J. 2005;26(5):440-6.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., McCabe, C. H., Braunwald, E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 2005;352(12):1179-89.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Lewis, B. S., Murphy, S. A., McCabe, C. H., Braunwald, E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA. 2005;294(10):1224-32.

Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial Am Heart J. 2005;149(2):227-33.

Sabatine, M. S., Morrow, D. A., Montalescot, G., Dellborg, M., Leiva-Pons, J. L., Keltai, M., Murphy, S. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Antman, E. M., Braunwald, E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial Circulation. 2005;112(25):3846-54.

Ahmed, S., Antman, E. M., Murphy, S. A., Giugliano, R. P., Cannon, C. P., White, H., Morrow, D. A., Braunwald, E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) J Thromb Thrombolysis. 2006;21(2):119-29. Abstract

Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A., Braunwald, E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med. 2006;354(14):1477-88.

Cannon, C. P. Evolving management of ST-segment elevation myocardial infarction: update on recent data Am J Cardiol. 2006;98(12A):10Q-21Q. Abstract

Charytan, D., Mauri, L., Agarwal, A., Servoss, S., Scirica, B., Kuntz, R. E. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients Am Heart J. 2006;152(3):558-64. Abstract

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Rohrbeck, S., Menon, V., Lins, J., Kazziha, S., Rokos, I., Shammas, N. W., Palabrica, T. M., Fish, P., McCabe, C. H., Braunwald, E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial Am Heart J. 2006;152(4):668-75. Abstract

Gibson, C. M., Ly, H. Q., Murphy, S. A., Ciaglo, L. N., Southard, M. C., Stein, E. B., Buros, J. L., Sabatine, M. S., Cannon, C. P. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28) Am J Cardiol. 2006;98(6):761-3.

Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.

Kirtane, A. J., Vafai, J. J., Murphy, S. A., Aroesty, J. M., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy Eur Heart J. 2006;27(17):2040-5.

Ly, H. Q., Kirtane, A. J., Murphy, S. A., Buros, J., Cannon, C. P., Braunwald, E., Gibson, C. M. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials) Am J Cardiol. 2006;98(1):5-Jan. Abstract

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., Braunwald, E. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial Circulation. 2006;114(4):281-8.

Pinto, D. S., Kirtane, A. J., Nallamothu, B. K., Murphy, S. A., Cohen, D. J., Laham, R. J., Cutlip, D. E., Bates, E. R., Frederick, P. D., Miller, D. P., Carrozza, J. P., Jr., Antman, E. M., Cannon, C. P., Gibson, C. M. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation. 2006;114(19):2019-25. Abstract

Scirica, B. M., Sabatine, M. S., Morrow, D. A., Gibson, C. M., Murphy, S. A., Wiviott, S. D., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Braunwald, E. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study J Am Coll Cardiol. 2006;48(1):37-42.

de Lemos, J. A., Wiviott, S. D., Murphy, S. A., Blazing, M. A., Lewis, E. F., Califf, R. M., Pfeffer, M. A., Braunwald, E. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial Am J Cardiol. 2006;98(6):739-42.

Fox, K. A., Antman, E. M., Montalescot, G., Agewall, S., SomaRaju, B., Verheugt, F. W., Lopez-Sendon, J., Hod, H., Murphy, S. A., Braunwald, E. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2249-55.

Gibson, C. M., Buros, J., Ciaglo, L. N., Southard, M. C., Takao, S., Harrigan, C., Filopei, J., Lew, M., Marble, S. J., Murphy, S. A., Cohen, M. G. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction Am J Cardiol. 2007;100(1):13-7. Abstract

Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2238-46.

Giraldez, R. R., Nicolau, J. C., Corbalan, R., Gurfinkel, E. P., Juarez, U., Lopez-Sendon, J., Parkhomenko, A., Molhoek, P., Mohanavelu, S., Morrow, D. A., Antman, E. M. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J. 2007;28(13):1566-73.

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Resnic, F. S. Validating an automated outcomes surveillance application using data from a terminated randomized, controlled trial (OPUS [TIMI-16]) AMIA Annu Symp Proc. 2007;NA(NA):1043. Abstract

McLean, D. S., Sabatine, M. S., Guo, W., McCabe, C. H., Cannon, C. P. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis. 2007;24(2):85-91.

Mega, J. L., Morrow, D. A., Ostor, E., Dorobantu, M., Qin, J., Antman, E. M., Braunwald, E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 2007;115(22):2822-2828. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Qin, J., Ruda, M., Guneri, S., Jacob, A. J., Budaj, A., Braunwald, E. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial Am Heart J. 2007;154(6):1078-84, 1084 e1.

Ruff, C. T., Wiviott, S. D., Morrow, D. A., Mohanavelu, S., Murphy, S. A., Antman, E. M., Braunwald, E. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction American Journal of Medicine. 2007;120(11):993-8. Abstract

Sabatine, M. S., Morrow, D. A., Dalby, A., Pfisterer, M., Duris, T., Lopez-Sendon, J., Murphy, S. A., Gao, R., Antman, E. M., Braunwald, E. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel J Am Coll Cardiol. 2007;49(23):2256-63.

Scirica, B. M., Morrow, D. A., Sadowski, Z., Ruda, M., Nicolau, J. C., Giugliano, R. P., Wiviott, S. D., Sabatine, M. S., Shui, A., Antman, E. M., Braunwald, E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study Eur Heart J. 2007;28(17):2070-6.

Steinberg, B. A., Moghbeli, N., Buros, J., Ruda, M., Parkhomenko, A., Raju, B. S., Garcia-Castillo, A., Janion, M., Nicolau, J. C., Fox, K. A., Morrow, D. A., Gibson, C. M., Antman, E. M. Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial Am Heart J. 2007;154(1):54-61.

Verheugt, F. W., Montalescot, G., Sabatine, M. S., Soulat, L., Lambert, Y., Lapostolle, F., Adgey, J., Cannon, C. P. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial J Thromb Thrombolysis. 2007;23(3):173-9.

White, H. D., Braunwald, E., Murphy, S. A., Jacob, A. J., Gotcheva, N., Polonetsky, L., Antman, E. M. Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25 Eur Heart J. 2007;28(9):1066-71.

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) ST-segment elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(4):223-31. Abstract

Gibson, C. M., Murphy, S. A., Pride, Y. B., Kirtane, A. J., Aroesty, J. M., Stein, E. B., Ciaglo, L. N., Southard, M. C., Sabatine, M. S., Cannon, C. P., Braunwald, E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J. 2008;155(1):133-9.

Gibson, C. M., Pride, Y. B., Buros, J. L., Kunadian, V., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Braunwald, E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol. 2008;101(9):1232-8.

Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol. 2008;51(5):546-51.

O'Donoghue, M., Morrow, D. A., Cannon, C. P., Guo, W., Murphy, S. A., Gibson, C. M., Sabatine, M. S. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J. 2008;29(8):984-91.

Pinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol. 2008;101(3):303-7.

Pride, Y. B., Buros, J. L., Lord, E., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days J Thromb Thrombolysis. 2008;26(2):106-12. Abstract

Sabatine, M. S., Hamdalla, H. N., Mehta, S. R., Fox, K. A., Topol, E. J., Steinhubl, S. R., Cannon, C. P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J. 2008;155(5):910-7.

Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation. 2008;117(15):1936-44.

Braunwald, E. [TIMI group study of thrombolysis in myocardial infarction] Ter Arkh. 2009;81(5):78-84. Abstract

Cheng, S., Morrow, D. A., Sloan, S., Antman, E. M., Sabatine, M. S. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation. 2009;119(9):1195-202.

Desai, N. R., Mega, J. L., Jiang, S., Cannon, C. P., Sabatine, M. S. Interaction between cigarette smoking and clinical benefit of clopidogrel Journal of the American College of Cardiology. 2009;53(15):1273-8. Abstract

Diercks, D. B., Kontos, M. C., Chen, A. Y., Pollack, C. V., Jr., Wiviott, S. D., Rumsfeld, J. S., Magid, D. J., Gibler, W. B., Cannon, C. P., Peterson, E. D., Roe, M. T. Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry J Am Coll Cardiol. 2009;53(2):161-6. Abstract

Gibson, C. M., Pride, Y. B., Aylward, P. E., Col, J. J., Goodman, S. G., Gulba, D., Bergovec, M., Kunadian, V., Zorkun, C., Buros, J. L., Murphy, S. A., Antman, E. M. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis J Thromb Thrombolysis. 2009;27(1):7-Nov.

Giraldez, R. R., Sabatine, M. S., Morrow, D. A., Mohanavelu, S., McCabe, C. H., Antman, E. M., Braunwald, E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American heart journal. 2009;157(3):517-24. Abstract

Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis Drugs. 2009;69(11):1433-43. Abstract

Montalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., Antman, E. M. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet. 2009;373(9665):723-31. Abstract

Pride, Y. B., Appelbaum, E., Lord, E. E., Sloan, S., Cannon, C. P., Sabatine, M. S., Gibson, C. M. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction Am J Cardiol. 2009;104(4):475-9.

Thomas, D., Giugliano, R. P. ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy J Thromb Thrombolysis. 2009;27(1):10-Jan. Abstract

Truong, Q. A., Cannon, C. P., Zakai, N. A., Rogers, I. S., Giugliano, R. P., Wiviott, S. D., McCabe, C. H., Morrow, D. A., Braunwald, E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial Am Heart J. 2009;157(4):673-9 e1. Abstract

Diercks, D. B., Owen, K. P., Kontos, M. C., Blomkalns, A., Chen, A. Y., Miller, C., Wiviott, S., Peterson, E. D. Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG) Am Heart J. 2010;160(1):80-87 e3. Abstract

Forman, D. E., Chen, A. Y., Wiviott, S. D., Wang, T. Y., Magid, D. J., Alexander, K. P. Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG) Am J Cardiol. 2010;106(10):1382-8. Abstract

Gibler, K. B., Huskamp, H. A., Sabatine, M. S., Murphy, S. A., Cohen, D. J., Cannon, C. P. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction Crit Pathw Cardiol. 2010;9(1):14-8. Abstract

Giugliano, R. P., Giraldez, R. R., Morrow, D. A., Antman, E. M., Gibson, C. M., Mohanavelu, S., Murphy, S. A., McCabe, C. H., Braunwald, E. Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial Eur Heart J. 2010;31(17):2103-10. Abstract

Harkness, J. R., Sabatine, M. S., Braunwald, E., Morrow, D. A., Sloan, S., Wiviott, S. D., Giugliano, R. P., Antman, E. M., Cannon, C. P., Scirica, B. M. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction Am Heart J. 2010;159(1):55-62. Abstract

Morrow, D. A., Antman, E. M., Fox, K. A., White, H. D., Giugliano, R., Murphy, S. A., McCabe, C. H., Braunwald, E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial European heart journal. 2010;31(17):2097-102. Abstract

Sherwood, M. W., Morrow, D. A., Scirica, B. M., Jiang, S. T., Bode, C., Rifai, N., Gerszten, R. E., Gibson, C. M., Cannon, C. P., Braunwald, E., Sabatine, M. S. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28 American Heart Journal. 2010;159(6):964-U3. Abstract

Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis. Circulation. 2010;122:2131-2141. Abstract

Wilson, Sean R., Wiviott, Stephen D., Antman, Elliott M., Giugliano, Robert P., Murphy, Sabina A., Sloan, Sarah, Braunwald, Eugene, Morrow, David A. APPLICATION OF THE TIMI RISK SCORE, A SIMPLE BEDSIDE TOOL, FOR TIMING OF DISCHARGE AFTER FIBRINOLYSIS OR PRIMARY ANGIOPLASTY FOR ST-ELEVATION MI IN THE EXTRACT-TIMI 25 AND TRITON-TIMI 38 TRIALS Journal of the American College of Cardiology. 2010;55(10, Supplement):A125.E1173.

Ahmed, S., Michael Gibson, C., Cannon, C. P., Murphy, S. A., Sabatine, M. S. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis J Thromb Thrombolysis. 2011;31(4):493-500. Abstract

Braunwald, E. Clinical efforts to reduce myocardial infarct size--the next step J Cardiovasc Pharmacol Ther. 2011;16(4-Mar):349-53. Abstract

Britton, K. A., Aggarwal, V., Chen, A. Y., Alexander, K. P., Amsterdam, E., Fraulo, E., Muntner, P., Thomas, L., McGuire, D. K., Wiviott, S. D., Roe, M. T., Schubart, U. K., Fox, C. S. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction Am Heart J. 2011;161(4):657-663 e1. Abstract

Desai, N. R., Morrow, D. A., Murphy, S. A., Gerszten, R. E., Cannon, C. P., Sabatine, M. S. Evaluation of Multiple Biomarkers of Cardiomyocyte Stress or Injury to Predict Cardiovascular Death or CHF in STEMI: Findings from CLARITY-TIMI 28 Circulation. 2011;124(21):NA.

Mathews, R., Peterson, E. D., Li, S., Roe, M. T., Glickman, S. W., Wiviott, S. D., Saucedo, J. F., Antman, E. M., Jacobs, A. K., Wang, T. Y. Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines Circulation. 2011;124(2):154-63. Abstract

Melloni, C., Roe, M. T., Chen, A. Y., Wang, T. Y., Wiviott, S. D., Ho, P. M., Peterson, E. D., Alexander, K. P. Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2011;4(6):603-9. Abstract

Toleva O, Westerhout CM, Senaratne M, Bode C, Lindroos M, Ardissino D, Sulimov VA, Montalescot G, Newby LK, Giugliano RP, Van de Werf F, Armstrong PW Association of Hub and Spoke Practice Patterns with Coronary Interventino and Outcomes in Non ST Elevation Acute Coronary Syndromes (NSTE ACS): Insights from the Early Glycoprotein IIb/IIIa Inhibition in NSTE ACS (EARLY-ACS) Trial J Am Coll Cardiol. 2011;57(14):74.

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Braunwald, E., Scirica, B. M. Improved Risk Stratification in Patients with ST-Elevation Myocardial Infarction Treated with Fibrinolysis by Combining New Q-Waves on the Initial Electrocardiogram with ST-Segment Resolution-Observations from the CLARITY-TIMI 28 Trial Circulation. 2011;124(21):NA.

Miller, Amy L., Holmes, DaJuanicia, Roe, Matthew T., Kontos, Michael C., Diercks, Deborah B., Amsterdam, Ezra, Bhatt, Deepak L., Wang, Tracy Y. Abstract 12552: Patient and Neighborhood Factors Associated with Presentation Delay in ST-Elevation Myocardial Infarction: Insights from the NCDR(R) Circulation. 2012;126(21 Supplement):A12552.

Mogabgab, O., Giugliano, R. P., Sabatine, M. S., Cannon, C. P., Mohanavelu, S., Wiviott, S. D., Antman, E. M., Braunwald, E. Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction Chronobiology International. 2012;29(10):1390-1396. Abstract

Shah, R. V., Holmes, D., Anderson, M., Wang, T. Y., Kontos, M. C., Wiviott, S. D., Scirica, B. M. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry Circ Heart Fail. 2012;5(6):693-702. Abstract

Agrawal, K., Bhatt, D. L. Antiplatelet therapy: Does prasugrel or ticagrelor suffice in patients with STEMI? Nat Rev Cardiol. 2013;10(3):121-2.

Amin, S. T., Morrow, D. A., Braunwald, E., Sloan, S., Contant, C., Murphy, S., Antman, E. M. Dynamic TIMI Risk Score for STEMI J Am Heart Assoc. 2013;2(1):e003269. Abstract

Buyukkaya, E., Poyraz, F., Karakas, M. F., Kurt, M., Akcay, A. B., Akpinar, I., Motor, S., Turak, O., Ozturk, O. H., Sen, N., Akpek, M., Kaya, M. G., Gibson, C. M. Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Am J Cardiol. 2013;NA(NA):NA. Abstract

Cavender, M. A., Rajeswaran, J., Di Paola, L., Houghtaling, P., Kiernan, M. S., Rassi, A. N., Menon, V., Whitlow, P. W., Ellis, S. G., Shishehbor, M. H. Outcomes of Culprit Versus Multivessel PCI in Patients With Multivessel Coronary Artery Disease Presenting With ST-Elevation Myocardial Infarction Complicated by Shock J Invasive Cardiol. 2013;25(5):218-24. Abstract

Cavender, M. A., Rassi, A. N., Fonarow, G. C., Cannon, C. P., Frank Peacock, W., Laskey, W. K., Hernandez, A. F., Peterson, E. D., Cox, M., Grau-Sepulveda, M., Schwamm, L. H., Bhatt, D. L. Relationship of Race/Ethnicity With Door-to-Balloon Time and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Findings From Get With the Guidelines-Coronary Artery Disease Clin Cardiol. 2013;NA(NA):NA. Abstract

Celik, T., Kaya, M. G., Akpek, M., Yarlioglues, M., Sarli, B., Topsakal, R., Gibson, C. M. Does Serum Bilirubin Level on Admission Predict TIMI Flow Grade and In-Hospital MACE in Patients With STEMI Undergoing Primary PCI Angiology. 2013;NA(NA):NA. Abstract

Chakrabarti, A. K., Feeney, K., Abueg, C., Brown, D. A., Czyz, E., Tendera, M., Janosi, A., Giugliano, R. P., Kloner, R. A., Weaver, W. D., Bode, C., Godlewski, J., Merkely, B., Gibson, C. M. Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction Am Heart J. 2013;165(4):509-514 e7. Abstract

Curzen, N., Gurbel, P. A., Myat, A., Bhatt, D. L., Redwood, S. R. What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention? Lancet. 2013;382(9892):633-43. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Secco, G. G., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors Heart Vessels. 2013;NA(NA):NA. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D., Egypt cooperation Impact of Hypertension on Distal Embolization, Myocardial Perfusion, and Mortality in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Am J Cardiol. 2013;112(8):1083-1086. Abstract

Genereux, P., Stone, G. W., Harrington, R. A., Gibson, C. M., Steg, P. G., Brener, S. J., Angiolillo, D. J., Price, M. J., Prats, J., Lasalle, L., Liu, T., Todd, M., Skerjanec, S., Hamm, C. W., Mahaffey, K. W., White, H. D., Bhatt, D. L. Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Goel, K., Pinto, D. S., Gibson, C. M. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review Am Heart J. 2013;165(4):451-67. Abstract

Kulik, A., Desai, N. R., Shrank, W. H., Antman, E. M., Glynn, R. J., Levin, R., Reisman, L., Brennan, T., Choudhry, N. K. Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event and Economic Evaluation (FREEE) Randomized Trial Circulation. 2013;128(26 Suppl 1):S219-25. Abstract

Martinez, G., Rigotti, A., Acevedo, M., Navarrete, C., Rosales, J., Giugliano, R. P., Corbalan, R. Cholesterol Levels and the Association of Statins With In-Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction Clin Cardiol. 2013;NA(NA):NA. Abstract

Mega, J. L., Braunwald, E., Murphy, S. A., Plotnikov, A., Burton, P., Kiss, R. G., Parkhomenko, A., Tendera, M., Widimsky, P., Gibson, C. M. Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Mogabgab, O., Wiviott, S. D., Antman, E. M., Foody, J. M., Wang, T. Y., Sabatine, M. S., Cannon, C. P., Li, S., Giugliano, R. P. Relation Between Time of Symptom Onset of ST-Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry Clin Cardiol. 2013;36(4):222-7. Abstract

Scirica, B. M., Kadakia, M. B., de Lemos, J. A., Roe, M. T., Morrow, D. A., Li, S., Wiviott, S. D., Kontos, M. C., on behalf of the National Cardiovascular Data, Registry Association between Natriuretic Peptides and Mortality among Patients Admitted with Myocardial Infarction: A Report from the ACTION Registry(R)-GWTG Clin Chem. 2013;NA(NA):NA. Abstract

Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S., Byrne, R. A., Jneid, H., Bhatt, D. L. Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013 Catheter Cardiovasc Interv. 2014;NA(NA):NA. Abstract

Kunadian, V., Giugliano, R. P., Newby, L. K., Zorkun, C., Guo, J., Bagai, A., Montalescot, G., Braunwald, E., Califf, R. M., Van de Werf, F., Armstrong, P. W., Harrington, R., Gibson, C. M. Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial) Am J Cardiol. 2014;113(8):1297-305. Abstract

Scirica, B. M. Evaluating the efficacy of mineralocorticoid receptor antagonism in patients with STEMI without heart failure Eur Heart J. 2014;NA(NA):NA.

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Scirica, B. M. Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Trial Clin Cardiol. 2014;37(3):160-6. Abstract